Efficacy of pulmonary rehabilitation in patients with post-acute COVID-19

Basit Öğe Kaydı
dc.authoridSOY, MEHMET/0000-0003-1710-7018
dc.authorwosidsoy, mehmet/AAD-5233-2020
dc.contributor.authorHantal, A. O.
dc.contributor.authorKayhan, S.
dc.contributor.authorSagmen, S. B.
dc.contributor.authorSoy, M.
dc.date.accessioned2024-05-19T14:40:34Z
dc.date.available2024-05-19T14:40:34Z
dc.date.issued2023
dc.departmentİstinye Üniversitesien_US
dc.description.abstractOBJECTIVE: The most important cause of mortality and morbidity of COVID-19 is lung involvement. In this study, the effects of pulmonary rehabilitation (PR) in the post-acute COVID-19 period on lung functions, functional capacity, dyspnea, quality of life, and psychiatric state were investigated. PATIENTS AND METHODS: Patients were admitted to a PR program after discharge when their general condition had stabilized. The patients' scores of forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), FEV1/FVC ratio, maximum vital capacity (VCmax), peripheral arterial oxygen saturation (PaO2), 6-minute walking distance (6MWD), Medical Research Council Dyspnea Scale (MRC), St. George Respiratory Questionnaire (SGRQ), and Hospital Anxiety and Depression Scale (HADS) before and after pulmonary rehabilitation were compared. The patients were divided into three groups, mild, moderate, and severe, according to their thorax CT findings. RESULTS: A total of 52 patients [mean age: 46.7 +/- 12.5 (range: 19-76) years] were included in the study. Nineteen patients were in the mild group, 16 in the moderate group, and 17 patients comprised the severe group. Comparing the parameters before and after PR, significant improvement was observed in all three groups in the evaluation parameters after treatment including FVC, FEV1, FEV1/FVC, 6MWD, and MRSC; SGRQ symptoms, activity, effects and total scores; HADS depression, anxiety, and total scores (p<0.05 for all). CONCLUSIONS: PR is a beneficial treatment for patients with COVID-19 with lung involvement for improving lung functions, eliminating dyspnea, and improving functional capacity, psychological status, and life quality of the patient.en_US
dc.identifier.endpage2126en_US
dc.identifier.issn1128-3602
dc.identifier.issue5en_US
dc.identifier.pmid36930511en_US
dc.identifier.scopus2-s2.0-85150666658en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage2117en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12713/4981
dc.identifier.volume27en_US
dc.identifier.wosWOS:000960863600012en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherVerduci Publisheren_US
dc.relation.ispartofEuropean Review For Medical and Pharmacological Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmz20240519_kaen_US
dc.subjectCovid-19en_US
dc.subjectPulmonary Rehabilitationen_US
dc.subjectPulmonary Functionsen_US
dc.subjectDepression And Anxiety Scalesen_US
dc.titleEfficacy of pulmonary rehabilitation in patients with post-acute COVID-19en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu